SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,954.76 373.76
( 0.48%)

Global Indices

Nasdaq

54,370.92 264.04
(0.49%)

Dow Jones

7,742.03 -15.49
(-0.20%)

Hang Seng

65,663.80 -636.64
(-0.96%)

Nikkei 225

10,894.52 15.14
(0.14%)

Forex

USD-INR

95.23 -0.06
(-0.07%)

EUR-INR

109.68 -0.11
(-0.10%)

GBP-INR

127.98 -0.19
(-0.15%)

JPY-INR

0.60 0.00
(-0.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524804

INE406A01037

391.1437121

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AUROPHARMA

38.59

93706.53

EPS(TTM)

Face Value()

Div & Yield %

41.81

0.25

Back

Strides Pharma Science consolidated net profit rises 57.52% in the June 2026 quarter

Jul 31,2026

Net profit of Strides Pharma Science rose 57.52% to Rs 156.91 crore in the quarter ended June 2026 as against Rs 99.61 crore during the previous quarter ended June 2025. Sales rose 13.01% to Rs 1265.41 crore in the quarter ended June 2026 as against Rs 1119.74 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1265.41	1119.74	13
OPM %	18.06	19.48	-
PBDT	192.82	179.30	8
PBT	136.42	130.41	5
NP	156.91	99.61	58

78,954.76 373.76 ( 0.48%)

54,370.92 264.04 (0.49%)

7,742.03 -15.49 (-0.20%)

65,663.80 -636.64 (-0.96%)

10,894.52 15.14 (0.14%)

95.23 -0.06 (-0.07%)

109.68 -0.11 (-0.10%)

127.98 -0.19 (-0.15%)

0.60 0.00 (-0.60%)